Introduction: hypercoagulable states.

Suppr

超能文献

作者信息

Bertina R M

机构信息

Haemostasis and Thrombosis Research Center, University Hospital Leiden, The Netherlands.

出版信息

Semin Hematol. 1997 Jul;34(3):167-70.

PMID:9241703

Abstract

摘要

相似文献

Introduction: hypercoagulable states.

Semin Hematol. 1997 Jul;34(3):167-70.

Resistance to activated protein C: a new etiology for hypercoagulable states.

Isr J Med Sci. 1995 Aug;31(8):510-2.

[Natural factors inhibiting blood coagulation (antithrombin III, protein C and protein S)].

Pol Tyg Lek. 1992;47(16-17):377-80.

Inflammation and thrombosis: the impact of inflammation on the protein C anticoagulant pathway.

Haematologica. 1995 Mar-Apr;80(2 Suppl):49-56.

Hypercoagulable states: molecular genetics to clinical practice.

Lancet. 1994;344(8939-8940):1739-42. doi: 10.1016/s0140-6736(94)92888-6.

Endogenous anticoagulants.

Top Companion Anim Med. 2012 May;27(2):81-7. doi: 10.1053/j.tcam.2012.07.003. Epub 2012 Sep 12.

Protein S deficiency.

Haematologica. 2008 Apr;93(4):498-501. doi: 10.3324/haematol.12691.

[Thrombin-mediated anticoagulation. The protein C/protein S/thrombomodulin system].

Tidsskr Nor Laegeforen. 1993 Nov 20;113(28):3450-2.

Genetic risk factors for venous thrombosis.

Mol Genet Metab. 2000 Sep-Oct;71(1-2):51-61. doi: 10.1006/mgme.2000.3051.

[Resistance to activated protein C: a new cause of hypercoagulability].

Ann Dermatol Venereol. 1996;123(1):37-9.

引用本文的文献

Interventions for restoring patency of occluded central venous catheter lumens.

Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD007119. doi: 10.1002/14651858.CD007119.pub2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Introduction: hypercoagulable states.

Semin Hematol. 1997 Jul;34(3):167-70.

Resistance to activated protein C: a new etiology for hypercoagulable states.

Isr J Med Sci. 1995 Aug;31(8):510-2.

[Natural factors inhibiting blood coagulation (antithrombin III, protein C and protein S)].

Pol Tyg Lek. 1992;47(16-17):377-80.

Inflammation and thrombosis: the impact of inflammation on the protein C anticoagulant pathway.

Haematologica. 1995 Mar-Apr;80(2 Suppl):49-56.

Hypercoagulable states: molecular genetics to clinical practice.

Lancet. 1994;344(8939-8940):1739-42. doi: 10.1016/s0140-6736(94)92888-6.

Endogenous anticoagulants.

Top Companion Anim Med. 2012 May;27(2):81-7. doi: 10.1053/j.tcam.2012.07.003. Epub 2012 Sep 12.

Protein S deficiency.

Haematologica. 2008 Apr;93(4):498-501. doi: 10.3324/haematol.12691.

[Thrombin-mediated anticoagulation. The protein C/protein S/thrombomodulin system].

Tidsskr Nor Laegeforen. 1993 Nov 20;113(28):3450-2.

Genetic risk factors for venous thrombosis.

Mol Genet Metab. 2000 Sep-Oct;71(1-2):51-61. doi: 10.1006/mgme.2000.3051.

[Resistance to activated protein C: a new cause of hypercoagulability].

Ann Dermatol Venereol. 1996;123(1):37-9.

引用本文的文献

Interventions for restoring patency of occluded central venous catheter lumens.

Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD007119. doi: 10.1002/14651858.CD007119.pub2.